Journal of Korean Traditional Oncology (대한암한의학회지)
- Volume 17 Issue 1
- /
- Pages.39-43
- /
- 2012
- /
- 1975-244X(pISSN)
- /
- 2765-4850(eISSN)
DOI QR Code
Long Term Survival of a Patient with Advanced Non-Small Cell Lung Cancer Treated with Allergen Removed Rhus verniciflua Stokes Extract; a Case Report
알러젠 제거 옻나무 추출물 단독치료로 생존기간 연장 및 삶의 질 개선을 보인 진행성 비소세포폐암 환자 1례
- Song, An-Na (Korean Traditional Medicine Cancer Center, Gangdong Kyunghee University Hospital) ;
- Ahn, Ji-Hye (Korean Traditional Medicine Cancer Center, Gangdong Kyunghee University Hospital) ;
- Kim, Kyung-Suk (Korean Traditional Medicine Cancer Center, Gangdong Kyunghee University Hospital) ;
- Jung, Hyun-Sik (Korean Traditional Medicine Cancer Center, Gangdong Kyunghee University Hospital) ;
- Lee, Soo-Kyung (Korean Traditional Medicine Cancer Center, Gangdong Kyunghee University Hospital) ;
-
Choi, Won-Cheol
(Korean Traditional Medicine Cancer Center, Gangdong Kyunghee University Hospital)
- 송안나 (강동경희대병원 한방암센터) ;
- 안지혜 (강동경희대병원 한방암센터) ;
- 김경석 (강동경희대병원 한방암센터) ;
- 정현식 (강동경희대병원 한방암센터) ;
- 이수경 (강동경희대병원 한방암센터) ;
-
최원철
(강동경희대병원 한방암센터)
- Received : 2012.06.12
- Accepted : 2012.06.22
- Published : 2012.06.28
Abstract
Objective : This study reports one case of a patient diagnosed with squamous cell carcinoma of the lung cancer with bone metastasis. Methods : A 56-year old male patient was diagnosed as squamous cell lung cancer in 1997 and received chemotherapy. The chemotherapy stopped after one cycle because of toxicity and the lung abscess. After four months from the diagnosis, rib metastasis was found and received the radiation therapy for two weeks. After the treatment, adverse effects such as nausea and anorexia appeared. The patient visited K. Korean Medicine Hospital and started the treatment with the allergen removed Rhus verniciflua stokes (aRVS) since December, 1997. Results and Conclusion : During treatment, the patient's quality of life had improved, and he had survived for 14 years after the administration of aRVS. This case suggests that aRVS can be an alternative treatment for the advanced NSCLC patients with bone metastasis.